| 622 |
cationic polyamidoamine dendrimer (nanoparticle)
|
|
319: Binding to ACE2 leading to lung fibrosis
|
| 809 |
Catecholamines
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 194 |
Carprofen
|
-
Carprofen, CAS-RN: 53716-49-7, DTXSID1045871
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 858 |
Carboplatin
|
-
Carboplatin, CAS-RN: 41575-94-4, DTXSID3046742
|
472: DNA adduct formation leading to kidney failure
|
| 601 |
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 602 |
Carbonyl cyanide m-chlorophenyl hydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 13 |
Carbon tetrachloride
|
-
Carbon tetrachloride, CAS-RN: 56-23-5, DTXSID8020250
|
38: Protein Alkylation leading to Liver Fibrosis
|
| 338 |
Carbon nanotubes, Multi-walled carbon nanotubes, single-walled carbon nanotubes, carbon nanofibres
|
|
2 AOPs
|
| 339 |
Carbon nanotubes, Multi-walled carbon nanotubes, Single-walled carbon nanotubes, carbon fibres
|
|
None
|
| 318 |
Carbon nanotubes
|
|
3 AOPs
|
| 740 |
Carbon black
|
-
Carbon black, CAS-RN: 1333-86-4, DTXSID7051216
|
451: Interaction with lung resident cell membrane components leads to lung cancer
|
| 822 |
Carbofuran
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 545 |
Carbenoxolone
|
-
Carbenoxolone, CAS-RN: 5697-56-3, DTXSID4022733
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 129 |
Carbendazim
|
-
Carbendazim, CAS-RN: 10605-21-7, DTXSID4024729
|
None
|
| 819 |
Carbaryl
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 92 |
Carbamazepine
|
-
Carbamazepine, CAS-RN: 298-46-4, DTXSID4022731
|
None
|
| 786 |
Carbamate pesticides
|
|
551: Increased Muscarinic M2 Receptor leading to Arrhythmia
|
| 595 |
Captan
|
-
Captan, CAS-RN: 133-06-2, DTXSID9020243
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 594 |
Captafol
|
-
Captafol, CAS-RN: 2425-06-1, DTXSID4020242
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 597 |
Capta
|
|
None
|
| 691 |
Candesartan cilexetil
|
-
Candesartan cilexetil, CAS-RN: 145040-37-5, DTXSID5020239
|
None
|
| 785 |
Camptothecin
|
|
550: Increased LMNA gene mutation leading to heart failure
|
| 841 |
calcium ionophore
|
|
None
|
| 380 |
Calcium channel blockers
|
|
261: L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility
|
| 456 |
Cadmium chloride
|
-
Cadmium chloride, CAS-RN: 10108-64-2, DTXSID6020226
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|